FOXO TECHNOLOGIES INC. Proceeds from Debt, Net of Issuance Costs
FOXO TECHNOLOGIES INC. (FOXO) reported Proceeds from Debt, Net of Issuance Costs of $2.92 million for the 1-month period ending 2022-09-20, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2024-06-28
- 2022-09-20: Proceeds from Debt, Net of Issuance Costs $2.92M; Proceeds from Debt, Net of Issuance Costs 1 month $2.92M.
| Period end | Proceeds from Debt, Net of Issuance Costs | Proceeds from Debt, Net of Issuance Costs 1 month |
|---|---|---|
| 2022-09-20 | $2.92M 10-Q · filed 2024-06-28 | $2.92M 10-K · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |